KATHRYN MORELAND: Open Payments
NPI 1275819674 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,334 in 155 payments from 24 companies in 2025. Trend: 2023 $2,922 · 2024 $3,108 · 2025 $3,334
Food & beverage: $3,334
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 35 | $825 |
| GlaxoSmithKline, LLC. | 35 | $612 |
| Insmed, Inc. | 17 | $361 |
| Regeneron Healthcare Solutions, Inc. | 18 | $266 |
| GENZYME CORPORATION | 7 | $243 |
| Pulmonx Corporation | 1 | $149 |
| Viatris Specialty LLC | 8 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $130 |
| Verona Pharma, Inc. | 5 | $110 |
| Amgen Inc. | 5 | $73 |
Products named: AIRSUPRA, DUPIXENT, TRELEGY ELLIPTA, FASENRA, Arikayce, NUCALA, TEZSPIRE, CHARTIS CATHETER.
Industry payments across TX — which companies pay providers there.
